Biotechnology Stocks I Performance Guide: Ionis Pharmaceuticals, Inc. (IONS)
IONS has no dividends
Table and Chart of IONS Performance
See what a $1,000 investment in IONS is worth today.
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| IONS Returns | |
|---|---|
| Start Date | Dec-31-2013 |
| Start Price | $39.84 |
| End Date | Dec-01-2023 |
| End Price | $51.63 |
| # Prices | 121 |
| Min Date | May-31-2016 |
| Min Price | $22.69 |
| Max Date | Mar-29-2019 |
| Max Price | $81.17 |
| Total Return | 29.59% |
| Annualized Return | 2.60% |
| Current Value of $1,000 Purchase | $1,296 |
| Number Returns | 7,260 |
| Average Return | 3.81% |
| Number Profitable Returns | 3,289 |
| Percent Profitable Returns | 45.30% |
| Number Unprofitable Returns | 3,971 |
| Percent Unprofitable Returns | 54.70% |
| Profitable to Unprofitable Returns Ratio | 0.83 |
| IONS Data | |
|---|---|
| VALUATION DATA | |
| Market Capitalization | $7,407,459,000 | Price to Sales | 12.04 |
| Earnings per Share | $-2.8700 |
| PE Ratio | None |
| PE to Growth Ratio | 25.7 |
| Price to Book | 23.49 |
| PRICE DATA | |
| 52 Week High | $51.89 |
| 52 Week Low | $32.69 |
| Analyst Target Price | $53.29 |
| 50-Day Moving Average | $46.78 |
| 200-Day Moving Average | $40.76 |
| FINANCIAL DATA | |
| Revenue per Share | $4.307 |
| Revenue | $615,031,000 |
| Profit Margin | -66.6% |
| Return on Equity | -0.9% |
| Stock Dividend, Valuation, Price and Financial Data Input | |
IONS Compare Returns with S&P 500
IONS Trendline Chart